Treatments for metastatic breast cancer have played a pivotal role in reducing mortality rates. Advances in targeted therapies, hormone therapies, and immunotherapies have improved the effectiveness of treatments, slowing disease progression and enhancing overall survival. Early detection, personalized treatment plans, and a multidisciplinary approach have also contributed. Patients now benefit from a more comprehensive understanding of the disease’s molecular characteristics, allowing for tailored interventions. Ongoing research and therapeutic innovations continue to shape the landscape, offering hope for improved outcomes and prolonged survival for individuals with metastatic breast cancer.
